Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Leukaemias myeloid NEC
ADR ID BADD_A02513
ADR Hierarchy
01      Blood and lymphatic system disorders
01.10      Leukaemias
01.10.08      Leukaemias myeloid NEC
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.01      Leukaemias
16.01.08      Leukaemias myeloid NEC
Description Not Available
MedDRA Code 10024309
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug Name
BADD_D00194Azacitidine
BADD_D00195Azathioprine
BADD_D00280Bleomycin
BADD_D00474Cisplatin
BADD_D00494Clodronic acid
BADD_D00549Cyclophosphamide
BADD_D00589Dasatinib
BADD_D00723Doxorubicin
BADD_D00871Felbamate
BADD_D00914Fludarabine
BADD_D01136Imatinib
BADD_D01253Lenalidomide
BADD_D01567Nilotinib
BADD_D01601Olaparib
BADD_D01609Omacetaxine mepesuccinate
BADD_D01799Ponatinib
BADD_D02002Selegiline
BADD_D02150Temozolomide
BADD_D02203Thiotepa
BADD_D02345Venetoclax
BADD_D02517Enasidenib
The 1th Page    1    Total 1 Pages